All patients (seven male, two female, average age 62.9 years) had elevated perioperative liver enzymes (GGT, AST, ALT) and a variety of comorbidities (steatosis 60%, steatohepatitis 33.3%, fibrosis 66.6%), and all received neoadjuvant chemotherapy prior to surgery. The gene discussed is GPT; the disease is steatosis.